Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury

Neuroscience

Volumn 120, Issue 4, 2003, Pages 951-960

  Widenfalk, J ^a   Lipson, A ^b   Jubran, M ^a   Hofstetter, C ^a   Ebendal, T ^c   Cao, Y ^d   Olson, L ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UPPSALA UNIVERSITY   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Angiogenesis; Flk 1; Flt 1; Ischemia; Neuropilin; Weight drop

Indexed keywords

ANGIOSTATIN; NEUROPILIN 1; NEUROPILIN 2; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD VESSEL; BRAIN CONCUSSION; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; DENSITY; DRUG DELIVERY SYSTEM; FEMALE; FETUS LIVER; GLIA CELL; IN SITU HYBRIDIZATION; INTRACELLULAR SPACE; NERVE CELL; NICK END LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; STATISTICAL ANALYSIS; WOUND HEALING;

EID: 0042133340     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00399-3     Document Type: Article

References (60)

1. Aczel, AD (1996) The Kruskal-Wallis test: a nonparametric alternative to one-way ANOVA. In: Complete business statistics (Aczel AD, ed), pp 653-659. Irwin: McGraw-Hill.
2. Anthes D.L., Theriault E., Tator C.H. Ultrastructural evidence for arteriolar vasospasm after spinal cord trauma. Neurosurgery. 39:1996;804-814.
3. Asahara T., Bauters C., Pastore C., Kearney M., Rossow S., Bunting S., Ferrara N., Symes J.F., Isner J.M. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon- injured rat carotid artery. Circulation. 91:1995;2793-2801.
4. Augustin H.G. Antiangiogenic tumour therapy will it work? Trends Pharmacol Sci. 19:1998;216-222.
5. Baffour R., Achanta K., Kaufman J., Berman J., Garb J.L., Rhee S., Friedmann P. Synergistic effect of basic fibroblast growth factor and methylprednisolone on neurological function after experimental spinal cord injury. J Neurosurg. 83:1995;105-110.
6. Balentine J.D. Pathology of experimental spinal cord trauma I . The necrotic lesion as a function of vascular injury. Lab Invest. 39:1978;236-253.
7. Bartholdi D., Rubin B.P., Schwab M.E. VEGF mRNA induction correlates with changes in the vascular architecture upon spinal cord damage in the rat. Eur J Neurosci. 9:1997;2549-2560.
8. Basso D.M., Beattie M.S., Bresnahan J.C. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 12:1995;1-21.
9. Basso D.M., Beattie M.S., Bresnahan J.C. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol. 139:1996;244-256.
10. Beattie M.S., Bresnahan J.C., Komon J., Tovar C.A., Van Meter M., Anderson D.K., Faden A.I., Hsu C.Y., Noble L.J., Salzman S., Young W. Endogenous repair after spinal cord contusion injuries in the rat. Exp Neurol. 148:1997;453-463.
11. Blight A.R. Morphometric analysis of blood vessels in chronic experimental spinal cord injury hypervascularity and recovery of function . J Neurol Sci. 106:1991;158-174.
12. Brandoli C., Shi B., Pflug B., Andrews P., Wrathall J.R., Mocchetti I. Dexamethasone reduces the expression of p75 neurotrophin receptor and apoptosis in contused spinal cord. Brain Res Mol Brain Res. 87:2001;61-70.
13. Braughler J.M., Duncan L.A., Chase R.L. Interaction of lipid peroxidation and calcium in the pathogenesis of neuronal injury. Cent Nerv Syst Trauma. 2:1985;269-283.
14. Cheng H., Cao Y., Olson L. Spinal cord repair in adult paraplegic rats partial restoration of hind limb function . Science. 273:1996;510-513.
15. Constantini S., Young W. The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats. J Neurosurg. 80:1994;97-111.
16. Crowe M.J., Bresnahan J.C., Shuman S.L., Masters J.N., Beattie M.S. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med. 3:1997;73-76.
17. Dagerlind Å., Friberg K.M., Bean A., Hökfelt T. Sensitive mRNA detection using unfixed tissue combined radioactive and non-radioactive in situ hybridization histochemistry . Histochemistry. 98:1992;39-49.
18. Dvorak H.F. VPF/VEGF and the angiogenic response. Semin Perinatol. 24:2000;75-78.
19. Facchiano, F, Pallini, R, Antonini, A, Lauretti, L, Miscusi, M, Sbriccoli, A, Capogrossi, M, Fernandez, E (1999) Effect of vascular endothelial growth factor on transected corticospinal tract axons. Society for Neuroscience annual meeting: 609.12, Miami Beach.
20. Fehlings M.G., Tator C.H., Linden R.D. The relationships among the severity of spinal cord injury, motor and somatosensory evoked potentials and spinal cord blood flow. Electroencephalogr Clin Neurophysiol. 74:1989;241-259.
21. Fitch M.T., Doller C., Combs C.K., Landreth G.E., Silver J. Cellular and molecular mechanisms of glial scarring and progressive cavitation in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma . J Neurosci. 19:1999;8182-8198.
22. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1:1995;27-31.
23. Gerber H.P., Hillan K.J., Ryan A.M., Kowalski J., Keller G.A., Rangell L., Wright B.D., Radtke F., Aguet M., Ferrara N. VEGF is required for growth and survival in neonatal mice. Development. 126:1999;1149-1159.
24. Gruner J.A. A monitored contusion model of spinal cord injury in the rat. J Neurotrauma. 9:1992;123-128.
25. Guest J.D., Hesse D., Schnell L., Schwab M.E., Bunge M.B., Bunge R.P. Influence of IN-1 antibody and acidic FGF-fibrin glue on the response of injured corticospinal tract axons to human Schwann cell grafts. J Neurosci Res. 50:1997;888-905.
26. 2+-accumulation in experimental spinal cord trauma. Brain Res. 211:1981;476-479.
27. Harada K., Grossman W., Friedman M., Edelman E.R., Prasad P.V., Keighley C.S., Manning W.J., Sellke F.W., Simons M. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest. 94:1994;623-630.
28. Holtz A., Nystrom B., Gerdin B. Relation between spinal cord blood flow and functional recovery after blocking weight-induced spinal cord injury in rats. Neurosurgery. 26:1990;952-957.
29. Johansson C.B., Momma S., Clarke D.L., Risling M., Lendahl U., Frisén J. Identification of a neural stem cell in the adult mammalian central nervous system. Cell. 96:1999;25-34.
30. Josephson A, Greitz D, Olson L, Spenger C (2001) A spinal thecal sac constriction model supports the theory that induced pressure gradients in the cord cause edema and cyst formation. Neurosurgery 48:636-646.
31. Kolodkin A.L., Levengood D.V., Rowe E.G., Tai Y.T., Giger R.J., Ginty D.D. Neuropilin is a semaphorin III receptor. Cell. 90:1997;753-762.
32. Kwo S., Young W., Decrescito V. Spinal cord sodium, potassium, calcium, and water concentration changes in rats after graded contusion injury. J Neurotrauma. 6:1989;13-24.
33. Lee T.T., Green B.A., Dietrich W.D., Yezierski R.P. Neuroprotective effects of basic fibroblast growth factor following spinal cord contusion injury in the rat. J Neurotrauma. 16:1999;347-356.
34. Lopez J.J., Laham R.J., Stamler A., Pearlman J.D., Bunting S., Kaplan A., Carrozza J.P., Sellke F.W., Simons M. VEGF administration in chronic myocardial ischemia in pigs. Cardiovasc Res. 40:1998;272-281.
35. Miao H.Q., Soker S., Feiner L., Alonso J.L., Raper J.A., Klagsbrun M. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility functional competition of collapsin-1 and vascular endothelial growth factor-165 . J Cell Biol. 146:1999;233-242.
36. Nag S., Takahashi J.L., Kilty D.W. Role of vascular endothelial growth factor in blood-brain barrier breakdown and angiogenesis in brain trauma. J Neuropathol Exp Neurol. 56:1997;912-921.
37. Nosrat C., Olson L. Brain-derived neurotrophic factor mRNA is expressed in the developing taste bud-bearing tongue papillae of rat. J Comp Neurol. 360:1995;698-704.
38. O'Reilly M.S., Holmgren L., Shing Y., Chen C., Rosenthal R.A., Moses M., Lane W.S., Cao Y., Sage E.H., Folkman J. Angiostatin a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma . Cell. 79:1994;315-328.
39. Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., Van Dorpe J., Hellings P., Gorselink M., Heymans S., Theilmeier G., Dewerchin M., Laudenbach V., Vermylen P., Raat H., Acker T., Vleminckx V., Van Den Bosch L., Cashman N., Fujisawa H., Drost M.R., Sciot R., Bruyninckx F., Hicklin D.J., Ince C., Gressens P., Lupu F., Plate K.H., Robberecht W., Herbert J.M., Collen D., Carmeliet P. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet. 28:2001;131-138.
40. Pasterkamp R.J., Giger R.J., Ruitenberg M.J., Holtmaat A.J., De Wit J., De Winter F., Verhaagen J. Expression of the gene encoding the chemorepellent semaphorin III is induced in the fibroblast component of neural scar tissue formed following injuries of adult but not neonatal CNS. Mol Cell Neurosci. 13:1999;143-166.
41. Pearlman J.D., Hibberd M.G., Chuang M.L., Harada K., Lopez J.J., Gladstone S.R., Friedman M., Sellke F.W., Simons M. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med. 1:1995;1085-1089.
42. Pettersson A., Nagy J.A., Brown L.F., Sundberg C., Morgan E., Jungles S., Carter R., Krieger J.E., Manseau E.J., Harvey V.S., Eckelhoefer I.A., Feng D., Dvorak A.M., Mulligan R.C., Dvorak H.F. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab Invest. 80:2000;99-115.
43. Quinn T.P., Peters K.G., De Vries C., Ferrara N., Williams L.T. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA. 90:1993;7533-7537.
44. Rabchevsky A.G., Fugaccia I., Fletcher-Turner A., Blades D.A., Mattson M.P., Scheff S.W. Basic fibroblast growth factor (bFGF) enhances tissue sparing and functional recovery following moderate spinal cord injury. J Neurotrauma. 16:1999;817-830.
45. Rothman S.M., Olney J.W. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol. 19:1986;105-111.
46. Schratzberger P., Schratzberger G., Silver M., Curry C., Kearney M., Magner M., Alroy J., Adelman L.S., Weinberg D.H., Ropper A.H., Isner J.M. Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy. Nat Med. 6:2000;405-413.
47. Shubik P., Feldman R., Garcia H., Warren B.A. Vascularization induced in the cheek pouch of the Syrian hamster by tumor and nontumor substances. J Natl Cancer Inst. 57:1976;769-774.
48. Skold M, Cullheim S, Hammarberg H, Piehl F, Suneson A, Lake S, Sjogren A, Walum E, Risling M (2000) Induction of VEGF and VEGF receptors in the spinal cord after mechanical spinal injury and prostaglandin administration. Eur J Neurosci 12:3675-3686.
49. Soker S., Takashima S., Miao H.Q., Neufeld G., Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 92:1998;735-745.
50. Sondell M., Lundborg G., Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci. 19:1999;5731-5740.
51. Tator C.H. Review of experimental spinal cord injury with emphasis on the local and systemic circulatory effects. Neurochirurgie. 37:1991;291-302.
52. Teng Y.D., Mocchetti I., Taveira-DaSilva A.M., Gillis R.A., Wrathall J.R. Basic fibroblast growth factor increases long-term survival of spinal motor neurons and improves respiratory function after experimental spinal cord injury. J Neurosci. 19:1999;7037-7047.
53. Teng Y.D., Mocchetti I., Wrathall J.R. Basic and acidic fibroblast growth factors protect spinal motor neurones in vivo after experimental spinal cord injury. Eur J Neurosci. 10:1998;798-802.
54. Wamil A.W., Wamil B.D., Hellerqvist C.G. CM101-mediated recovery of walking ability in adult mice paralyzed by spinal cord injury. Proc Natl Acad Sci USA. 95:1998;13188-13193.
55. Wen Y., Edelman J.L., Kang T., Zeng N., Sachs G. Two functional forms of vascular endothelial growth factor receptor-2/Flk-1 mRNA are expressed in normal rat retina. J Biol Chem. 273:1998;2090-2097.
56. Widenfalk J., Lundströmer K., Jubran M., Brené S., Olson L. Neurotrophic factors and receptors in the immature and adult spinal cord after mechanical injury or kainic acid. J Neurosci. 21:2001;3457-3475.
57. Widenfalk J., Olson L., Thoren P. Deprived of habitual running, rats downregulate BDNF and TrkB messages in the brain. Neurosci Res. 34:1999;125-132.
58. Williams B., Terry A.F., Jones F., McSweeney T. Syringomyelia as a sequel to traumatic paraplegia. Paraplegia. 19:1981;67-80.
59. Yamane A., Seetharam L., Yamaguchi S., Gotoh N., Takahashi T., Neufeld G., Shibuya M. A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1). Oncogene. 9:1994;2683-2690.
60. Young W., Koreh I. Potassium and calcium changes in injured spinal cords. Brain Res. 365:1986;42-53.